Fecal leukocytes are white blood cells found in stool, and their presence generally signals that something is inflaming or damaging the lining of the intestines. High levels point toward invasive bacterial infections, inflammatory bowel disease, or other conditions that physically disrupt the gut wall. Low or absent levels, on the other hand, suggest that diarrhea or other symptoms are more likely caused by viruses, toxin-producing bacteria, or non-inflammatory processes that leave the intestinal lining intact. The test has been in clinical use for over a century, though its role has narrowed considerably as newer stool markers have taken over much of the diagnostic work it once performed.
How the Test Works
The standard fecal leukocyte test is straightforward. A small sample of stool is smeared onto a glass slide, stained with methylene blue dye, and examined under a microscope. The stain highlights the nuclei of white blood cells, making them visible against the background of digested food and bacteria. A technician then counts the number of leukocytes per high-power field. Anything above about five white blood cells per field is typically considered positive, though different labs use slightly different cutoffs.
The test is quick and cheap, which is why it was widely used for decades as a first-pass screen before ordering slower, more expensive tests like stool cultures or toxin assays for pathogens like Clostridium difficile.1PubMed Central. Fecal leukocyte stain has diagnostic value for outpatients but not inpatients The idea was simple: if white blood cells are flooding into the gut in large numbers, the diarrhea is likely caused by a pathogen that invades the intestinal wall, and it is worth culturing the stool to identify it. If leukocytes are absent, the cause is probably something that does not physically damage the tissue, and culture may be unnecessary.
What Elevated Fecal Leukocytes Indicate
When fecal leukocyte counts are high, the intestinal lining is under active assault. The white blood cells, mostly neutrophils, migrate from the bloodstream through the epithelial layer and into the intestinal lumen in response to tissue invasion or inflammation. This process itself can worsen symptoms and damage crypt architecture, the microscopic glands that line the colon.2PubMed Central. Neutrophil-Epithelial Crosstalk During Intestinal Inflammation
The most common causes of elevated fecal leukocytes fall into two broad categories: invasive bacterial infections and chronic inflammatory conditions.
Invasive Bacterial Infections
Shigella is the classic example. It invades the cells lining the colon, triggers an intense inflammatory response, and produces diarrhea that often contains visible blood and mucus along with high fecal leukocyte counts.3PubMed Central. Epidemiology of bacterial pathogens associated with infectious diarrhea in Djibouti Salmonella, Campylobacter, and invasive strains of E. coli behave similarly, though the degree of inflammation varies. In children, certain diarrheagenic E. coli strains, particularly enterotoxigenic E. coli (ETEC), have been linked to elevated fecal leukocytes even though they are not traditionally classified as invasive pathogens. One study found that ETEC isolated as a single pathogen carried roughly four times the odds of producing more than ten leukocytes per high-power field compared to controls, though the overall inflammatory response was described as mild.4PubMed Central. Fecal leukocytes in children infected with diarrheagenic Escherichia coli
It is worth noting that even among invasive infections, fecal leukocytes do not always appear. Specimen handling matters: white blood cells degrade quickly at room temperature, so a stool sample that sits around for hours before reaching the lab may look falsely negative. The cells can also be destroyed by cytotoxic substances in the stool itself.
Inflammatory Bowel Disease
In people with Crohn’s disease or ulcerative colitis, chronic intestinal inflammation drives a persistent influx of neutrophils into the gut. Fecal biomarkers, including leukocytes, have shown a correlation with disease activity, and studies have found that markers like calprotectin and lactoferrin, which are proteins released by those same neutrophils, track reasonably well with how active the inflammation is.5PubMed. Review of fecal biomarkers in inflammatory bowel disease However, the fecal leukocyte test itself is not a reliable tool for monitoring IBD. One study comparing biomarkers against biopsy results found that the leukocyte count had a sensitivity of just over five percent for detecting inflammation, meaning it missed the vast majority of cases where biopsy confirmed active disease.6PubMed Central. Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results The specificity was high, but a test that almost never turns positive when disease is present is not clinically useful for screening or monitoring purposes.
When Fecal Leukocytes Stay Low
A negative or low fecal leukocyte result does not mean nothing is wrong. It means the problem is probably not one that physically invades or erodes the intestinal lining. Viral gastroenteritis, the most common cause of acute diarrhea worldwide, rarely produces fecal leukocytes because viruses like norovirus and rotavirus damage cells higher up in the gut (the small intestine) and do not provoke the same neutrophil-heavy response that colonic invasion does.
Toxin-mediated food poisoning also tends to produce clean fecal leukocyte results. When Staphylococcus aureus or Bacillus cereus causes vomiting and diarrhea, it is the preformed toxin doing the damage, not the bacterium itself invading tissue. The gut lining may be irritated, but it is not being physically broken into by bacteria, so neutrophils do not flood the area. Similarly, cholera produces profuse watery diarrhea through a toxin mechanism without significant tissue invasion, and fecal leukocytes are characteristically absent.
Certain parasitic infections also keep leukocyte counts low. Giardia, for instance, attaches to the surface of the small intestine without invading it, and diarrhea from giardiasis is typically non-inflammatory. This stands in contrast to amoebic dysentery, which does invade the colonic wall and can produce leukocytes, though microscopic examination of stool for amoebic trophozoites remains the more targeted diagnostic approach for that infection.
Diagnostic Accuracy and the Setting Problem
The usefulness of fecal leukocytes as a diagnostic tool depends heavily on context. In outpatient settings, where most diarrheal illness is caused by a relatively narrow set of pathogens, the test performs reasonably well as a screen. One study at a pediatric hospital found that a cutoff of more than five leukocytes per high-power field achieved about 63 percent sensitivity and 84 percent specificity for invasive diarrheal disease.7PubMed. Accuracy of fecal lactoferrin and other stool tests for diagnosis of invasive diarrhea at a Colombian pediatric hospital Those are decent numbers for a quick, inexpensive screen, though they also mean about a third of true invasive infections would be missed.
In hospitalized patients, the picture changes. Inpatients have a much broader range of reasons for diarrhea, including medications, tube feeding, post-surgical complications, and infections with organisms like C. difficile that produce toxins rather than invading tissue directly. One assessment of the fecal leukocyte test in inpatients found high specificity for detecting intact colonic mucosa (about 92 percent), meaning a positive result was fairly reliable at flagging mucosal damage.8PubMed Central. Performance assessment of the fecal leukocyte test for inpatients But the test’s overall ability to guide clinical decisions in this population was limited because so many causes of inpatient diarrhea are non-inflammatory. Research comparing the test across settings has found that it holds diagnostic value for outpatients but not for inpatients, where the mix of underlying conditions is simply too diverse for a single inflammatory marker to be a useful gatekeeper.1PubMed Central. Fecal leukocyte stain has diagnostic value for outpatients but not inpatients
Lactoferrin, Calprotectin, and the Shift Away From the Microscope
One of the biggest practical problems with counting fecal leukocytes under a microscope is that white blood cells are fragile. They start breaking down almost immediately once they leave the body, especially in stool that is watery, acidic, or not kept cold. If a sample is not examined promptly, the cells can disintegrate beyond recognition, turning a true positive into a false negative.
This fragility led researchers to look for more durable molecular proxies. Lactoferrin, a protein found in the granules of neutrophils, was one of the first. It remains stable in stool even when the cells that released it have long since broken apart, so it can be detected reliably in specimens that have been stored or transported. A test using anti-lactoferrin antibody was developed as a marker for fecal leukocytes specifically to address the problem of cells being morphologically lost in swab specimens or destroyed during transport or by cytotoxic stool.9PubMed Central. Measurement of fecal lactoferrin as a marker of fecal leukocytes
Calprotectin, another neutrophil-derived protein, has become the dominant fecal biomarker in gastroenterology over the past two decades. It is stable at room temperature for up to a week, can be measured with a simple immunoassay, and correlates more tightly with endoscopic findings than the raw leukocyte count does. For distinguishing inflammatory bowel disease from irritable bowel syndrome, fecal calprotectin has largely replaced both fecal leukocytes and lactoferrin in clinical guidelines. Its superiority is especially clear in the IBD monitoring context, where the microscopic leukocyte count proved almost useless.6PubMed Central. Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results
The American College of Gastroenterology’s clinical guideline on acute diarrheal infections acknowledges this shift directly. The guideline notes that while the decision to obtain a stool culture was historically guided by fecal leukocytes or lactoferrin, using these markers to direct further diagnostic testing has been shown to be imprecise and probably unnecessary.10American Journal of Gastroenterology. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults Modern multiplex stool PCR panels can identify dozens of pathogens in one test within hours, making the question of “should we culture?” less relevant than it was when culture was the only option and took days to return a result.
Parasitic Infections and Fecal Leukocytes
Parasites are a mixed bag when it comes to fecal leukocytes, and this variability can actually be informative when the clinical picture is ambiguous. The key distinction is whether the parasite invades the intestinal wall or just attaches to its surface.
Entamoeba histolytica, the cause of amoebic dysentery, burrows into the colonic mucosa and can produce flask-shaped ulcers. This tissue invasion triggers a robust inflammatory response, including neutrophil recruitment and, consequently, fecal leukocytes. Research comparing the host response in amoebiasis versus giardiasis has confirmed that amoebic infection provokes stronger inflammatory, oxidative stress, and tissue injury responses, consistent with its invasive nature.11PubMed. Comparative inflammatory, oxidative stress, and tissue injury signatures in amoebiasis and giardiasis Giardiasis, by contrast, stays on the surface of the small intestine and typically does not elevate fecal leukocytes at all.
Other parasites fall somewhere in between. Intestinal worms like hookworm can cause eosinophils (a different type of white blood cell) to appear in stool, but these are not the neutrophils that the standard fecal leukocyte test is designed to detect. Cryptosporidiosis can produce a modest inflammatory response in the small bowel, but fecal leukocytes are not a reliable indicator. For most parasitic infections, direct microscopy of the stool for ova and parasites or antigen testing remains the appropriate diagnostic approach rather than relying on leukocyte counts.
Fecal Leukocytes in Infants and Young Children
The test takes on a somewhat different meaning in very young children. Infants in the first year of life, particularly those who are breastfed, can have small numbers of leukocytes in their stool without any pathological process at play. The immature gut is still developing its barrier function, and low-grade immune cell trafficking across the intestinal wall is part of normal development.
A condition that specifically affects infants is allergic proctocolitis, which is a food-protein allergy (usually to cow’s milk protein) that causes microscopic inflammation in the rectum and lower colon. These babies may have streaks of blood in their stool and can show fecal leukocytes on testing. A recent study examining whether persistent fecal leukocyte excretion in infants with allergic proctocolitis predicted worse weight gain or progression to other allergies found that persistent leukocyte excretion did not affect weight gain, and the inflammatory stool markers had limited predictive value for the condition’s course.12PubMed. The Association of Persistent Fecal White Blood Cell Excretion with Impaired Weight Gain and Food Allergy Among Children with Allergic Proctocolitis In other words, finding white blood cells in the stool of an infant with suspected milk allergy does not tell you much about how the child will do.
For pediatric acute bloody diarrhea, some expert reviews have gone further and explicitly recommended against using fecal leukocytes, calprotectin, or lactoferrin for diagnosis, on the grounds that these markers do not reliably change management.13Jornal de Pediatria. Acute diarrhea with blood: diagnosis and drug treatment When a child has bloody diarrhea, clinicians already know there is mucosal damage. The leukocyte count adds little to what is already obvious from the clinical presentation.
How the Test First Entered Medicine
The idea of looking at white blood cells in stool is older than most people assume. In 1918, two researchers named Willmore and Shearman examined the stools of over a thousand patients with dysentery in Egypt and published one of the earliest accounts of how the distribution and shape of cells in stool could help distinguish amoebic dysentery from bacillary (bacterial) dysentery. They argued that microscopic examination of the cellular material shed into stool was faster and more accurate than stool culture.14JAMA Internal Medicine. Devolution and Devaluation of Fecal Leukocyte Testing: A 100-Year History For much of the twentieth century, they were right: culture was slow, expensive, and not available in many settings, while a methylene blue stain could be done with a microscope and a few minutes.
The test’s trajectory since then has been described as a “devolution and devaluation.” Each generation of newer diagnostic tools, from enzyme immunoassays to PCR-based panels, chipped away at the situations where fecal leukocyte counting remained the best available option. Today, it persists mainly in resource-limited settings where rapid molecular diagnostics are not available and in certain clinical algorithms as a low-cost initial screen. Its legacy, though, is significant: the concept that stool can be examined for inflammatory markers led directly to the development of lactoferrin and calprotectin testing, both of which owe their clinical rationale to the original observation that white blood cells in stool mean something is wrong with the gut wall.